Select Language

LAG3

Product Inquiry

English Name	Research Code	Highest Development Stage	Company	Indication	Clinical Trial
OR-2805	OR-2805	Phase 2 Clinical	OncoResponse Inc	Solid tumours; Leiomyosarcoma; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Liposarcoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Melanoma	Details

English Name	Research Code	Highest Development Stage	Company	First Brand Name	First Approved Country	First Indication	First Approved Company	First Approved Date	Indication	Clinical Trial
Tetrachlorodecaoxide	TCDO; WF-10; OXO-K993	Approved	Nuvox Pharma LLC	WF10, Oxoferin, Immunokine	Thailand	Rhinitis, Allergic; Inflammation	null	1997-01-01	Diabetic Foot; HIV Infections; Rhinitis, Allergic; Inflammation	Details